The Oncosearch | Oncotarget

N-(2Â´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells Research Paper

Arturo Contis-Montes de Oca, EstefanÃa Rodarte-Valle, Martha Cecilia Rosales-HernÃ¡ndez, Edgar Abarca-Rojano, SaÃºl Rojas-HernÃ¡ndez, Manuel Jonathan Fragoso-VÃ¡zquez, Jessica Elena Mendieta-Wejebe, Ana MarÃa Correa-Basurto, Ismael VÃ¡zquez-Moctezuma, JosÃ© Correa-Basurto

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33368-33381

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Research Paper

Manoranjan Sahoo, Gajendra K. Katara, Mahmood Y. Bilal, Safaa A. Ibrahim, Arpita Kulshrestha, Sara Fleetwood, Kimiko Suzue, Kenneth D. Beaman

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33215-33231

Autotaxin-Î² interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis Research Paper

Raphael Leblanc, Debashish Sahay, Audrey Houssin, Irma Machuca-Gayet, Olivier Peyruchaud

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33170-33185

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

Vikas Dembla, Neeta Somaiah, Pedro Barata, Kenneth Hess, Siqing Fu, Filip Janku, Daniel D. Karp, Aung Naing, Sarina Anne Piha-Paul, Vivek Subbiah, Apostolia M. Tsimberidou, Kenna Shaw, Funda Meric-Bernstam, David S. Hong

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33232-33243

Correction: Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations Correction

Bhimashankar Gurushidhappa Utage, Milind Shivajirao Patole, Punam Vasudeo Nagvenkar, Sonali Shankar Kamble, Rajesh Nivarti Gacche

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 33050-33050

CXCR4 antagonists for treatment of breast cancer Editorial

Javier CortÃ©s, Esther Holgado, Jose Perez-Garcia

Published Aug 29, 2018 · Vol. 9, No. 71 · pp. 33442-33443

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, Mikita Suyama

Published Aug 24, 2018

Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo Correction

Hong Yang, Liuyuan Guan, Shun Li, Ying Jiang, Niya Xiong, Li Li, Chunhui Wu, Hongjuan Zeng, Yiyao Liu

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32730-32730

RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue Research Paper

Michael Forster, Adam Mark, Friederike Egberts, Elisa Rosati, Elke Rodriguez, Martin Stanulla, Dirk Bauerschlag, Christian Schem, Nicolai Maass, Anu Amallraja, Karla K. Murphy, Bruce R. Prouse, Raed A. Sulaiman, Brandon M. Young, Micaela Mathiak, Georg Hemmrich-Stanisak, David Ellinghaus, Stephan Weidinger, Philip Rosenstiel, Norbert Arnold, Brian Leyland-Jones, Casey B. Williams, Andre Franke, Tobias MeiÃŸner

Published Aug 17, 2018 · Vol. 9, No. 64 · pp. 32362-32372

3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition Research Paper

Ying Wang, Sameer Mirza, Shaohua Wu, Jiping Zeng, Wen Shi, Hamid Band, Vimla Band, Bin Duan

Published Aug 14, 2018 · Vol. 9, No. 63 · pp. 32191-32203

A nomogram prediction for the survival of patients with triple negative breast cancer Research Paper

Yuxiang Lin, Fangmeng Fu, Songping Lin, Wei Qiu, Wei Zhou, Jinxing Lv, Chuan Wang

Published Aug 14, 2018 · Vol. 9, No. 63 · pp. 32108-32118

Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis Research Paper

Fanxin Zeng, Jiangping Fu, Fang Hu, Yani Tang, Xiangdong Fang, Fanwei Zeng, Yanpeng Chu

Published Aug 14, 2018 · Vol. 9, No. 63 · pp. 32149-32160

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer Correction

Mirelle Lagendijk, Sepideh Saadatmand, Linetta B. Koppert, Madeleine M.A. Tilanus-Linthorst, Vanja de Weerd, Raquel RamÃrez-Moreno, Marcel Smid, Anieta M. Sieuwerts, John W.M. Martens

Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 32096-32096

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Alberto OcaÃ±a, Eitan Amir, Atanasio Pandiella

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31915-31919

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX Research Paper

Theodore Vougiouklakis, Vassiliki Saloura, Jae-Hyun Park, Naofumi Takamatsu, Takashi Miyamoto, Yusuke Nakamura, Yo Matsuo

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31820-31831

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality Research Paper

Ismael da Silva, Rene da Costa Vieira, Carolina Stella, Edson Loturco, AndrÃ© Lopes Carvalho, Carlos Veo, Cristovam Neto, Sandra M. Silva, Paulo D'Amora, Marcia Salzgeber, Delcio Matos, Celso R. Silva, Jose R. Oliveira, Iara Rabelo, Patricia Yamakawa, Rui Maciel, Rosa Biscolla, Maria Chiamolera, Renato Fraietta, Felipe Reis, Marcelo Mori, Dirce Marchioni, Antonio Carioca, Gustavo Maciel, Renato Tomioka, Edmund Baracat, Clovis Silva, Celso Granato, Ricardo Diaz, Bruno Scarpellini, Daniel Egle, Heidi Fiegl, Irmgard Himmel, Christina Troi, Robert Nagourney

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31664-31681

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications Research Paper

Angela Toss, Federico Piacentini, Laura Cortesi, Lucia Artuso, Isabella Bernardis, Sandra Parenti, Elena Tenedini, Guido Ficarra, Antonino Maiorana, Anna Iannone, Claudia Omarini, Luca Moscetti, Massimo Cristofanilli, Massimo Federico, Enrico Tagliafico

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31606-31619

Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer Research Paper

Vincent Fleury, Ludovic Ferrer, Mathilde ColombiÃ©, DaniÃ©la Rusu, MaÃ«lle Le Thiec, FranÃ§oise Kraeber-BodÃ©rÃ©, LoÃ¯c Campion, Caroline Rousseau

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31744-31752

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Jordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, Wael Harb, Analia Azaro, Yu Han, Celine Wilke, Valerie Donnet, Dalila Sellami, Thaddeus Beck

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31709-31718

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T Research Paper

Jonathan Klein, Wilfred W. Lam, Gregory J. Czarnota, Greg J. Stanisz

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31490-31501

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

N-(2Â´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells Research Paper

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Research Paper

Autotaxin-Î² interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis Research Paper

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

Correction: Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations Correction

CXCR4 antagonists for treatment of breast cancer Editorial

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo Correction

RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue Research Paper

3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition Research Paper

A nomogram prediction for the survival of patients with triple negative breast cancer Research Paper

Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis Research Paper

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer Correction

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX Research Paper

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality Research Paper

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications Research Paper

Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer Research Paper

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

N-(2Â´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells Research Paper

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Research Paper

Autotaxin-Î² interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis Research Paper

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

Correction: Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations Correction

CXCR4 antagonists for treatment of breast cancer Editorial

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo Correction

RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue Research Paper

3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition Research Paper

A nomogram prediction for the survival of patients with triple negative breast cancer Research Paper

Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis Research Paper

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer Correction

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX Research Paper

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality Research Paper

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications Research Paper

Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer Research Paper

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T Research Paper